XML 49 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Options and Equity Estimated Based on Weighted Average Assumptions

 

    Year Ended December 31,
    2021   2020
Risk-free interest rate   0.66% - 1.23%   0.3% - 0.46%
Expected dividend yield    
Expected life   5 years   5 years
Expected volatility   108.08% - 108.46%   115.24% - 116.79%
Weighted average grant date fair value for options issued   $1.61 per option for 613,512 options   $2.28 per option for 1,025,000 options
Schedule of Warrants Outstanding and Exercisable

Information regarding warrants outstanding and exercisable into shares of common stock is summarized below:

 

   2021   2020 
   Shares   Warrant
Price
   Weighted
Average
Exercise
Price
   Shares   Warrant
Price
   Weighted
Average
Exercise
Price
 
Outstanding, beginning of year    375,100   $0.99469.92   $116.38    10,201,761   $ 0.99469.92   $1.54 
Granted                        
Expired   (79,593)   17.1684.48    20.85             
Exercised   (568)   8.80    8.80    (9,826,661)   0.90-8.80    0.97 
Outstanding, end of year   294,939   $ 0.99-469.92   $15.19    375,100   $0.99469.92   $116.38 
Exercisable   294,939   $ 0.99-469.92   $15.19    375,100   $ 0.99469.92   $116.38 
Weighted average remaining contractual life   4.75 years              5.75 years           
Years exercisable   2022-2025                                        2021-2024                                    

Share-based Payment Arrangement, Employee [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity

Stock option activity for employees

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contracted
Term
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding December 31, 2019   127,747   $29.61    6.41     
Granted   925,000    2.28    9.78     
Forfeited   (2,483)   19.50         
Expired   (569)   348.48         
Outstanding December 31, 2020   1,049,695   $5.38    9.28     
Granted   500,000    1.60    9.11     
Forfeited   (50,897)              
Expired                
Outstanding December 31, 2021   1,498,798   $4.22    9.11     
Vested and expected to vest at December 31, 2021   1,498,798   $4.22    9.11     
Exercisable at December 31, 2021   1,086,298   $3.52    7.96     
Schedule of Unvested Stock Option Activity

Unvested stock option activity for employees:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Average
Remaining
Contracted
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested December 31, 2019   30,100   $23.79    7.48     
Granted   925,000    2.28    9.78     
Vested   (226,254)   3.93    7.53     
Forfeited                
Unvested December 31, 2020   728,846   $3.71    9.61     
Granted   449,102    1.60    9.11     
Vested   (765,448)   2.24    8.36     
Forfeited                
Unvested December 31, 2021   412,500   $4.15    5.85     
Share-based Payment Arrangement, Nonemployee [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity

Stock option activity for non-employees during the year:

 

   Number
of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contracted
Term
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding December 31, 2019   66,675   $12.80    5.59     
Granted   100,000    2.77         
Exercised                
Forfeited   (142)   104.29         
Outstanding December 31, 2020   166,533   $11.03    6.88     
Granted   113,512    1.64    9.92     
Exercised                
Forfeited   (322)   965.93         
Outstanding December 31, 2021   279,723   $6.12    7.93     
Vested and expected to vest at December 31, 2021   279,723   $6.12    7.93     
Exercisable at December 31, 2021   181,892   $7.11    7.53     
Schedule of Unvested Stock Option Activity

Unvested stock option activity for non-employees:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contracted
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested December 31, 2019   25,566   $12.80    5.59     
Granted   100,000    2.77    9.58     
Vested   (59,364)   5.95         
Forfeited                
Unvested December 31, 2020   66,202   $7.24    6.13     
Granted   113,512    1.64    9.92     
Vested   (81,883)   3.48         
Forfeited                
Unvested December 31, 2021   97,831   $3.89    7.82     
2009 Equity Incentive Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity

Information regarding the options approved by the Board of Directors under Equity Plan of 2009 is summarized below. The plan expired June 24, 2019:

 

   2021   2020 
   Shares   Option
Price
   Weighted
Average
Exercise
Price
   Shares   Option
Price
   Weighted
Average
Exercise
Price
 
Outstanding, beginning of year   129,680    13.202,127.84    23.05    132,615    13.20 -2,127.84    31.65 
Granted                         
Forfeited   (1,176)   16.76-1056.00    289.62    (2,935)   9.68380.16    82.38 
Exercised                        
Outstanding, end of year   128,504    13.20-2,127.84    25.58    129,680    13.20 - 2,127.84    23.05 
Exercisable, end of year   126,393    13.20-2,127.84         98,138    13.202,127.84      
Weighted average remaining contractual life (years)    5.9 years                                         5.6 years                                       
2018 Equity Incentive Plans [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity

Information regarding the options approved by the Board of Directors under the Equity Plan of 2018 is summarized below:

 

   2021   2020 
   Shares   Option
Price
   Weighted
Average
Exercise
Price
   Shares   Option
Price
   Weighted
Average
Exercise
Price
 
Outstanding, beginning of year   1,086,549    1.85 - 9.68    2.75    61,806    9.68    9.68 
Granted   613,512    1.111.71    1.67    1,025,000    1.85 3.07    2.33 
Forfeited   (50,044)   1.858.50    1.86    (257)   9.6816.72    2.75 
Exercised                        
Outstanding, end of year   1,650,017    1.119.68    2.35    1,086,549    1.85 9.68    2.75 
Exercisable, end of year   1,141,798    1.119.68    2.35    243,750    1.85 9.68    2.75 
Weighted average remaining contractual life (years)   9.12 years               9.4 years           
Available for future grants   344,322              28,268